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Abstract
Background: Impaired cardiac output (CO) is a key element of heart failure (HF). So far,
there has been no simple, reliable, inexpensive and non-invasive CO measurement method
feasible for clinical practice. Not a single diagnostic test has been elaborated to diagnose and
monitor HF. The aim of the study was the evaluation of the reliability of a new, non-invasive
CO measurement device utilizing an inert gas rebreathing technique and an infrared
photoacoustic gas analyzer, in comparison with standard invasive methods.
Methods: In 21 patients with advanced HF (NYHA classes III and IV) undergoing cardiac
catheterization as a routine hemodynamic evaluation before heart transplantation, CO meas-
urements with the tested non-invasive method were carried out during invasive examination.
Results: CO measured by the inert gas rebreathing technique (CORB), according to the statis-
tical Bland-Altman method, was, on average, 0.1 L/min higher than that determined by
thermodilution (COTD) and 0.006 L/min higher than the CO determined by the Fick formula
(COFick). This magnitude of difference equals 2.8% of COTD and 0.15% of COFick values. The
limits of agreement between CORB and COTD were ± 1.4 L/min, and between CORB and COFick
± 1.3 L/min. In the subgroup with atrial fibrillation, the mean difference between tested and
reference methods (0.3 ± 1.0 L/min for both COTD and COFick) was higher than in the sinus
rhythm subgroup (0.06 ± 1.5 L/min for COTD and 0.08 ± 1.5 for COFick).
Conclusions: CO measurement with the inert gas rebreathing method utilizing an infrared
photoacoustic gas analyzer seems reliable enough to be employed in clinical practice. Being
non-invasive, it may well be used for repeated determinations in patients with HF. (Cardiol J
2008; 15: 63–70)
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Introduction
Depressed cardiac output (CO) below the de-
mands of metabolizing tissues is a key element of
heart failure (HF) definition, but, in practice, it is
hardly ever used to support diagnosis [1]. Current-
ly, CO is mainly measured invasively, predominant-
ly in end-stage HF patients qualifying as heart trans-
plant recipients [2]. Introducing a simple and relia-
ble non-invasive CO measurement would make the
parameter clinically more relevant. An estimation
of CO could be useful during diagnosis verification
in patients suspected of having HF, or in following-
up disease progression and/or responses to treat-
ment. Systematically repeated tests could reveal
occult deterioration of cardiac function and give
a rationale for pharmacological treatment intensifi-
cation or for introducing non-pharmacological ther-
apy with heart transplantation on the top. The se-
verity of heart failure is currently estimated main-
ly on the basis of subjective exercise tolerance
limitation (NYHA classification), but not only cir-
culatory compromise can cause a patient to feel
unable to exercise. Subjective exercise endurance
depends both on organic disabilities (HF, chronic
obstructive lung disease, anemia) and on emotion-
al state [3]. In less advanced HF, CO can be normal
at rest but fails to rise properly during exertion. In
such a group of patients, CO measurements during
exercise are more relevant. Maximal oxygen uptake
(VO2max), appreciated as a valuable prognostic fac-
tor in chronic HF, is in fact an indirect derivate of
CO [4]. The prognostic value of exercise-induced
CO change is indeed higher [5] but the invasive-
ness of current procedures makes these tests use-
less for wider clinical practice and encourages the
use of an indirect derivate (VO2max) instead of
a primary parameter (CO) [6]. The prognostic sig-
nificance of CO in HF patients can be enhanced by
taking into consideration actual blood pressure.
Cardiac power output is a product of CO and mean
arterial blood pressure. The accuracy of this param-
eter was proved for hemodynamic data obtained
invasively. If the same is true for CO measured non-
invasively, we could obtain a valuable prognostic
parameter for most heart failure patients, even
those with less advanced disease [3]. In reality,
a reliable, simple and non-invasive hemodynamic
prognostic parameter in heart failure is still miss-
ing [6]. The clinical experience with the inert gas
rebreathing method using an infrared photoacous-
tic gas analyzer in patients with heart failure is en-
couraging but still limited to a small number of pa-
tients mainly in NYHA classes II and III [7].
The aim of our study was to evaluate the accu-
racy of the inert gas rebreathing method in com-
parison with standard invasive methods in advanced
chronic heart failure patients, NYHA class III and IV,
who had qualified as potential heart transplant
recipients.
Methods
Patients
The study population consisted of patients suf-
fering from advanced HF despite optimal treatment
after all other options of treatment had been ex-
hausted. On the basis of symptoms and non-inva-
sive tests, the patients had qualified as potential
heart transplant recipients. Contraindications to
cardiac transplantation or cardiac catheterization
were exclusion criteria for our study. Right-heart
catheterization was performed as a standard proce-
dure to verify the existence of hemodynamic con-
traindications to transplantation. Local ethical com-
mittee approval for the study was obtained, and the
study was carried out according to the tenets of the
Declaration of Helsinki. Before the procedure, in-
formed consent was obtained from each patient for
participation in the study.
The performance of invasive tests was preced-
ed by practice of the rebreathing technique to make
the patient familiar with the tested equipment be-
fore the procedure (usually 2–3 attempts were suf-
ficient). During this phase, foreign gases were not
added to the gas mixture and CO was not calculat-
ed. In a cath-lab, a Swan-Ganz catheter was insert-
ed, pressures in the appropriate vessels and cham-
bers measured, and both arterial and mixed venous
blood sampled for COFick measurement. In the cal-
culations, estimated oxygen consumption was used.
COTD was repeated five times using in-line injec-
tions of 10 mL iced saline. Extreme values were
rejected and from the remaining three closest meas-
urements, the mean value was calculated. Immedi-
ately after thermodilution, inert gas rebreathing
measurements were performed twice at 5-minute
intervals. The mean value of the results was calcu-
lated. All CO measurements were performed with
the patient in the supine position.
Cardiac output determination
by the gas rebreathing method
Inert gas rebreathing determination was per-
formed using an Innocor device (Innovision, Den-
mark) equipped with an infrared photoacoustic gas
analyzer, instead of the mass-spectrometer used
before. Two types of physiologically inert gases
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were used in the device: one being blood-soluble
N2O and the other blood-insoluble SF6. Their initial
concentrations in the gas mixture were 0.5% and
0.1% respectively. The rate of washout of the blood-
soluble compound (N2O) reflects effective pulmo-
nary capillary blood flow, which equals CO until no
significant intrapulmonary or intracardiac shunt is
present. Blood-insoluble SF6 was used to determine
lung vital capacity, tightness of the system and the
accuracy of gas mixing between the rebreathing bag
and alveolar air. The initial volume of the gas mix-
ture in the rebreathing bag was programmed as 30%
of the predicted forced vital capacity, reduced by 10%.
During the procedure, 4–5 breaths were performed
in a closed system. The changes in gas concentra-
tions recorded during two or three initial breaths
were automatically excluded from the calculations
due to insufficient gas mixing between the rebreath-
ing bag and alveolar air.
Statistical analysis
Apart from the Pearson correlation coefficient,
we used the Bland and Altman method for calculat-
ing the mean difference and the limits of agreement
between the two diagnostic tests. The mean differ-
ences reflect the bias, i.e. systematic difference
between methods, and the limits of agreement de-
scribe the random fluctuation around the mean. The
value of the limits of agreement were calculated by
adding and deducting from the mean difference the
doubled standard deviation (SD) of the differences
(more precisely 1.96 ± SD), which describe, with
95% probability, the maximal magnitude of differ-
ence between the results obtained with the tested
method and the reference method. In our study, the
differences between results obtained by each meth-
od according to this formula were presented as
a mean difference 1.96 ± SD. The correlations were
presented as a correlation coefficient — r and level
of significance — p [2, 8].
Results
The characteristics of the enrolled patients are
summarized in Table 1 (demographic and clinical
data) and Table 2 (hemodynamic data). After the
exclusion of one patient who was intolerant to the
mouthpiece (due to a vomitory reflex), the study
group consisted of 21 patients in NYHA classes
III and IV. With this group, 27 series of measurements
were performed using each method (three patients
were catheterized twice and one underwent 48-hour
hemodynamic monitoring with four sets of measure-
ments). The mean CO was: 3.91 L/min if measured
with the thermodilution method (COTD); 3.98 L/min
with the Fick method (COFick); and 3.99 L/min with
the tested inert gas rebreathing method (CORB).
For the entire study group, the mean CORB was
0.1 ± 1.4 L/min higher than COTD (the magnitude
of difference equals 2.8% of COTD value) (Fig. 1). In
the case of atrial fibrillation, the mean CORB was 0.3 ±
± 1.0 L/min higher than COTD (7.4% COTD); where-
as, in the subgroup with sinus rhythm, the mean
CORB was 0.06 ± 1.5 L/min lower than COTD (1.4%
COTD). Correlation coefficients between the results
obtained by both methods were, respectively,
r = 0.7529 (p < 0.001) for the entire study group,
r = 0.7699 (p < 0.001) for patients with sinus
rhythm, and r = 0.8909 (p = 0.003) for patients with
atrial fibrillation (Table 3).
Values of CORB were slightly higher than values
of COFick in the entire population (0.006 ± 1.3 L/min,
mean difference accounts for 0.2% of COFick value)
(Fig. 2) and in the subgroup with atrial fibrillation
(0.258 ± 1.1 L/min, 6.7% of COFick value); whereas,
in patients with sinus rhythm, values of CORB were
slightly lower than COFick (0.081 ± 1.5 L/min =
= 2% of COFick value). Correlations between the
methods were as follows: in the entire group, r =
= 0.7835 (p < 0.001); in patients with atrial fibril-
lation, r = 0.8816 (p = 0.004); and r = 0.7769
(p < 0.001) in patients with sinus rhythm (Table 3).
Discussion
CO measured with the non-invasive gas re-
breathing method equipped with the photoacoustic
gas analyzer (CORB) differed by only –0.1 L/min
(2.8% of COTD value) from CO measured by
Table 1. Characteristics of the study group.
Variable Value
Age 46.5 years
Gender 1 female, 20 male
Time after diagnosis of HF 4.9 years
Ischemic cardiomyopathy 5 (24%)
Dilated cardiomyopathy 16 (76%)
Sinus rhythm 16 (76%)
Atrial fibrillation 5 (24%)
NYHA class III 13 (62%)
NYHA class IV 8 (38%)
Ejection fraction 28±8.4%
Left ventricle diameter diastole  7.1±1.0 cm
Left ventricle diameter systole  5.6±1.1 cm
Data expressed as mean ± SD, or number and percentage;
NYHA — New York Heart Association; HF — heart failure
66
Cardiology Journal 2008, Vol. 15, No. 1
www.cardiologyjournal.org
thermodilution. Dispersion of the differences be-
tween the results obtained by the compared meth-
ods was, nevertheless, considerable (limits of
agreement ± ± 1.5 L/min) (Fig. 1, Table 3). Tak-
ing into account the limits of agreement, the value
of CORB can be from 1.6 L/min lower to 1.4 L/min
higher than COTD. However, the difference between
CORB and COTD (–0.1 ± 1.4 L/min) was comparable
to that between COFick and COTD (–0.07 ± 1.5 L/min)
(Fig. 3, Table 3). In the entire study group, correla-
tions between all used methods were statistically
significant (r > 0.5 and p < 0.05) (Table 3).
Similar results were obtained by Gabrielsen
and Videbaek, who evaluated an older model of the
device equipped with a similar photoacoustic gas
analyzer (AMIS2001). In a group of 21 patients, the
mean difference between CORB and COTD (continuous
thermodilution technique) was –1.0 ± 0.8 L/min [9].
Table 2. Hemodynamic characteristics.
Hemodynamic Measured values
Mean Minimal Maximal
RAP m 14 8 31 2–6 [mm Hg]
PAP s 46 27 74 < 25 [mm Hg]
PAP d 25 12 44 < 10 [mm Hg]
PAP m 33 18 54 < 20 [mm Hg]
PAWP 23 12 41 8–12 [mm Hg]
PAP m – PAWP 10 1 24 2–10 [mm Hg]
Sat a O2 96 89 99 > 95 (%)
Sat v O2 64 51 77 60–75 (%)
COTD 3.9 2.3 5.4
COFick 4.0 2.2 6.3 4–8 [L/min]
CORB 4.0 2.2 6.4
CITD 2.0 1.2 3.0
CIFick 2.1 1.1 3.5 2.5–4 [L/min/m2]
CIRB 2.0 1.2 3.6
SVTD 54 24 105
SVFick 55 30 95 50–100 [mL/beat]
SVRB 55 23 107
SITD 28 13 51
SIFick 28 15 46 25–45 [mL/beat/m2]
SIRB 28 12 51
PVRTD 2.8 0.2 9.2
PVRFick 2.8 0.3 10.8 1.5–2.5 [Wood Units]
PVRRB 2.9 0.2 7.9
PVRITD 5.4 0.4 17.7
PVRIFick 5.3 0.6 20.7 1–3 [Wood Units × m2]
PVRIRB 5.5 0.4 15.1
SVRTD 18.9 11.9 28.4
SVRFick 18.7 10.1 28.7 11.25–16.25 [Wood Units]
SVRRB 19.0 10.8 37.0
SVRITD 36.7 23.9 51.0
SVRIFick 36.3 20.1 56.1 23.75–30 [Wood Units × m2]
SVRIRB 36.4 19.9 62.3
RAP — right atrium pressure, PAP — pulmonary artery pressure, PAWP — pulmonary artery wedge pressure; SatO2 — blood O2 saturation; v — mixed venous;
a — arterial; m — mean, s — systolic, d — diastolic; CO — cardiac output, CI — cardiac output index, SV — stroke volume, SI — stroke volume index,
PVR and PVRI — pulmonary vascular resistance and its index, SVR and SVRI — systemic resistance and its index; TD — parameters measured by
thermodilution, Fick — by Fick, RB — rebreathing method
parameters
Normal ranges
[Units]
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Peyton and Thompson compared the accuracy of the
Innocor in a group of nine patients with normal left
ventricular systolic function during elective cardio-
surgery. They carried out 20 series of measure-
ments. The mean difference between CORB and
COTD (with ambient temperature saline) was
0.01 ± 1.7 L/min with a correlation coefficient of
r = 0.57. The mean difference between CORB and
COFick was 0.3 ± 2.5 L/min (r = 0.52) [1]. Agostoni
compared CORB with traditional invasive measure-
ments during cardiopulmonary exercise tests in
20 patients with chronic, systolic HF, predominant-
ly in NYHA class II. The correlation coefficient
r for CORB vs. COTD was 0.9382; CORB vs. COFick
0.9482 and COTD vs. COFick 0.9465 (p value not pub-
lished). In Agostoni’s study, the mean CORB exceed-
ed both the mean for COFick (by 0.1 L/min) and COTD
Figure 1. Accuracy of CORB against COTD in whole stu-
died group — Bland Altman diagram; CO — cardiac
output: TD — measured by thermodilution, RB — by
rebreathing method.
Table 3. Comparison of cardiac output determined by different methods.
Reference method          COTD          COFick
Accuracy        Correlation Accuracy   Correlation
[L/min] [L/min]
Mean Limits of r p Mean Limits of r p
differ- agreement differ- agreement
ence ± 1.96 SD ence ± 1.96 SD
CORB Whole group –0.109 1.434 0.753 < 0.001 –0.006 1.343 0.784 < 0.001
Sinus rhythm +0.056 1.474 0.770 < 0.001 +0.081 1.453 0.777 < 0.001
Atrial fibrillation –0.285 0.963 0.891 < 0.001 –0.258 1.052 0.882 0.004
COFick Whole group –0.071 1.505 0.656 < 0.001
Sinus rhythm –0.025 1.532 0.692 0.002
Atrial fibrillation +0.061 0.854 0.871 0.002
CO — cardiac output measured by (COFick) Fick, (COTD) thermodilution, or (CORB) rebreathing method
Figure 3. Accuracy of COFick against COTD in whole stu-
died group — Bland Altman diagram; CO — cardiac
output: TD — measured by thermodilution, Fick — by
Fick method.
Figure 2. Accuracy of CORB against COFick in whole studied
group — Bland Altman diagram; CO — cardiac output:
Fick — measured by Fick, RB — by rebreathing method.
Compared
method
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(by 0.6 L/min; thermodilution with iced saline) [10].
The stronger correlation between the CO determi-
nation techniques obtained by Agostini than by oth-
er authors may result from the higher number of
performed measurements (95) and/or from a homo-
geneity of the studied population.
The mean difference between the gas rebreath-
ing method and invasive methods, both in the authors’
own research and in quoted studies, was relatively small
(from 0.01 L/min to maximal 1.0 L/min). The limits of
agreement seem, nonetheless, quite wide (mean ±
± 1.5 L/min). Taking in the mean difference (0.1 L/min
was assumed) and limits of agreement, the CORB may
underestimate the actual CO value by a maximum of
1.4 L/min, or overestimate it by 1.6 L/min.
There are no obligatory criteria for the accept-
able magnitude of the difference between CO esti-
mation methods, allowing them to be used inter-
changeably. COFick determined using measured ver-
sus calculated oxygen consumption differs by 0.04 ±
± 3.3 L/min [11]. The extent of the difference by no
means eliminates from regular practice COFick meas-
urement using calculated oxygen consumption.
Shoemaker studied the clinical significance of CO
differences measured by impedance and thermodi-
lution in a group of 680 circulatory instable patients.
The mean difference (based on 2192 pairs of meas-
urements) between cardiac index — CI measured
by these methods was 0.12 ± 0.75 L/min/m2 and did
not result in a difference in accuracy of therapeutic
decisions [12]. In our study, the mean difference
between CIRB and CITD was –0.04 ± 0.799 L/min/m2.
According to Shoemaker’s conclusions, clinical de-
cisions based on CORB and COTD should not differ.
CORB is calculated from the rate of nitrous
oxide washout from the gas mixture as a result of
its pulmonary blood absorption. For the sake of the
calculations, it is assumed that the gas dissolves in
circulating blood only. It has not been studied to
what extent gas dissolving in the blood congested
in the lungs may influence the concentration drop
in the rebreathing air and, consequently, CO calcu-
lation [13]. The amount, insignificant in healthy
humans, may prove important and responsible for
a cardiac output overestimation in patients with
pulmonary congestion. It is possible, however, that
the gas dissolves in retained blood only during the
initial breaths, which was automatically excluded
from analysis. So far, the studies using nitrous ox-
ide for CO determination in heart failure patients
have been few and did not solve this problem [9, 10].
Gabrielsen et al. [9] compared CO determined by
similar rebreathing equipment and a continuous ther-
modilution method in 10 patients (II and III NYHA
classes) during cardiac catheterization at rest (prob-
ably in a supine position). The mean CORB was 1.0 ±
± 0.8 L/min lower than for COTD. In the second part
of the study, gas rebreathing, thermodilution
and Fick were compared. The mean CORB was
0.1 ± 0.9 L/min lower; whereas, COTD was 0.8 ±
± 1.3 L/min higher in comparison to COFick [9]. In both
parts of this study, the rebreathing method underesti-
mated CO against thermodilution by c. 1.0 L/min. Ago-
stoni et al. [10] measured cardiac output during an
exercise test in the sitting position in a group of
20 patients, predominantly in NYHA class II. In this
study, CORB was, on average, 0.6 L higher than COTD
(measured with iced saline) and 0.1 L/min higher
than COFick. In both presented studies, patients dif-
fered with heart failure severity, body position dur-
ing the test and thermodilution technique. It seems
plausible that the shift of ventilation/perfusion ra-
tio caused by the change of body position influenc-
es CO measurements by the rebreathing method,
at least in patients with heart failure. Earlier stud-
ies, however, proved that CORB remains accurate
after a change of body position, despite alteration
in the ventilation/perfusion ratio [14]. The results
of the ESCAPE study showed that the intensity of
dyspnoea in heart failure correlates with capillary
wedge pressure [15]. Therefore, more intense dys-
pnoea suggests greater pulmonary congestion.
Patients in lower NYHA classes (in the aforemen-
tioned studies of classes I and II) are less likely to
have substantial pulmonary congestion than pa-
tients with more advanced heart failure (classes III
and IV in the present study). Such a mechanism
might explain why, in Gabrielsen’s study, CORB was
lower, as opposed to our own study in which it was
higher than CO measured invasively.
CORB is calculated as the sum of effective cap-
illary pulmonary blood flow and functional pulmo-
nary shunt. Ignoring existing shunt in calculations
results in CO underestimation. In calculations,
a drop in arterial blood saturation below 98% is as-
sumed to be a sign of significant pulmonary shunt.
However, shunt is not the sole factor lowering ar-
terial blood saturation. In advanced HF, desatura-
tion of mixed venous blood secondary to low CO
may be so great that, despite the lack of shunt, ar-
terial blood saturation remains reduced. If, under
such circumstances, correction based on a drop in
arterial blood saturation is performed, CO by re-
breathing will overestimate the real one [9, 10].
In our study group, arterial blood saturation exceed-
ed 98% only in 10 measurements. After correcting
the value of effective pulmonary blood flow deter-
mined with the tested device by the value of the
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calculated pulmonary shunt, neither the mean er-
ror nor correlation coefficient improved. In Gabri-
elsen’s study, taking into account the pulmonary
shunt improved accuracy of the gas rebreathing
method against COFick, the limits of agreement
changed from 0.6 ± 1.2 L/min to 0.3 ± 0.9 L/min [9].
In our study, the correlation between subse-
quent COTD measurements was high in the entire
group (r = 0.96), in the subgroup with sinus rhythm
(r = 0.96), and the group with atrial fibrillation
(r = 0.95; for all the correlations p < 0.001). The
Bland and Altman analysis revealed that the repeat-
ability of subsequent COTD determinations was high
(–0.03 L/min in the entire population, –0.02 L/min
in the subgroup with sinus rhythm, and –0.03 L/min
in patients with atrial fibrillation); whereas, the lim-
its of agreement were nearly twice as high in the
group with atrial fibrillation (± 0.44 L/min) as in the
entire study group (± 0.27 L/min) and in patients
with sinus rhythm (± 0.16 L/min). This is in accord-
ance with reports by other authors, who point out
the adverse influence of atrial fibrillation on the re-
peatability of thermodilution CO determinations [16].
This fact is of utmost importance for cardiac failure
patients as atrial fibrillation and other arrhythmias
are more frequent than in the general population.
We analyzed the influence of atrial fibrillation on the
accuracy of CORB measurements against COTD.
In the sinus rhythm subgroup, the mean difference
between CORB and COTD was smaller (+0.06 ±
± 1.5 L/min) than in the entire study group (–0.1 ±
± 1.4 L/min) and patients with atrial fibrillation
(–0.29 ± 0.96 L/min). A similar relation was observed
when comparing CORB and COFick (–0.01 ± 1.3 L/min
in the entire population, 0.08 ± 1.5 L/min in the
subgroup with sinus rhythm and –0.26 ± 1.1 L/min
in atrial fibrillation). The differences between par-
ticular methods may well be explained differently.
The Fick method reflects the average cardiac out-
put over the period of time necessary to cause gas
concentration changes in arterial and venous blood
(about 2–3 min), but both thermodilution and gas
rebreathing methods express temporary values (re-
flecting 10–15 s) [17]. The difference between COTD
and CORB is, thus, the difference between two tem-
porary determinations separated by time. The dif-
ferences between COFick and CORB or COTD are dif-
ferences between the mean and temporary values.
These differences are of no importance at stable
rhythm and stable stroke volume. If, however, sig-
nificant changes of CO occur quickly, as in rhythm
disturbances, the differences are reflected as a wid-
er distribution of values — both within one method
and between methods. In atrial fibrillation, the
changes are especially vivid, where the stroke vol-
ume of each myocardial contraction has a random
value (with some contractions hemodynamically
ineffective).
The ESCAPE study, evaluating hemodynamic
monitoring in decompensated HF, revealed a slight-
ly better functional improvement in invasively moni-
tored patients. Nonetheless, an increase in survival or
shortening of hospitalization was not observed [15].
If it emerges that non-invasive measurements are
equally helpful in achieving greater functional im-
provement, the tests may well be performed more
often. Non-invasive monitoring would then change
the daily practice of cardiology departments treat-
ing patients with decompensated heart failure [18–
–20]. However, for the time being, literature is lack-
ing in data concerning the gas rebreathing method
in the monitoring of decompensated heart failure
patients.
Limitations of the study
Calculated values were used instead of meas-
ured ones, due to the impossibility of determining
oxygen consumption in the Fick formula. Thus, our
COFick values involve a degree of estimation error.
The limited number of patients in the studied pop-
ulation did not allow us to conduct subgroup analy-
ses. The low number of patients included in the
study resulted from the fact that hemodynamic in-
vasive tests in advanced stable heart failure are
currently rarely performed.
Conclusions
1. Our study shows that the inert gas rebreath-
ing method is a reliable technique for determin-
ing cardiac output in patients with advanced
heart failure. Measurements are most accurate
in patients with sinus rhythm.
2. It may be expected that the reliability of the
method is sufficient to make proper clinical
decisions. This comfortable, simple and non-
invasive method means that measurements can
be repeated frequently in patients with heart
failure and, potentially, may be used in the
monitoring of heart failure patients.
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